| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $252.4M | +9.1% |
| Cost of Revenue | $112.6M | +14.7% |
| Gross Profit | $139.8M | +5.1% |
| R&D Expense | $25.2M | +16.6% |
| SG&A Expense | $45.9M | +39.4% |
| Operating Income | -$38.2M | -2186.9% |
| Interest Expense | $5.7M | +125.1% |
| Pre-tax Income | -$80.7M | -2484.1% |
| Income Tax | $1.6M | +23.8% |
| Net Income | -$82.3M | -4093.2% |
| EPS (Basic) | -$4.39 | -3758.3% |
| EPS (Diluted) | -$4.39 | -4090.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.9M | -11.1% |
| Short-term Investments | $171.4M | — |
| Accounts Receivable | $45.6M | +44.9% |
| Inventory | $63.6M | +61.1% |
| Current Assets | $451.2M | +80.7% |
| Total Assets | $521.0M | +85.9% |
| Current Liabilities | $105.8M | +43.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.0M | -5524.7% |
| Capital Expenditures | $22.7M | +2136.3% |
| Investing Cash Flow | -$194.2M | — |
| Financing Cash Flow | $242.9M | +106.7% |
| Free Cash Flow | -$89.7M | — |
| Total Liabilities |
| $536.2M |
| +139.7% |
| Stockholders' Equity | -$15.2M | -126.8% |